Immediate Impact

2 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Drug-resistant tuberculosis: a persistent global health concern
2024 Standout
2 intermediate papers

Works of Melissa A. Bender being referenced

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy
2012
Cost‐Effectiveness of Tenofovir as First‐Line Antiretroviral Therapy in India
2009

Author Peers

Author Last Decade Papers Cites
Melissa A. Bender 108 58 152 104 16 433
Mansour Farahani 129 29 177 117 22 474
Daniel Shine 59 34 56 115 21 389
Jaime Younger 120 72 177 110 11 409
Kathryn Chu 128 59 336 38 10 470
Valerie J. Ehlers 205 46 167 68 47 488
Sumeet Sodhi 187 39 206 93 19 459
Marie‐Claude Lavoie 62 44 187 34 31 383
Madeleine Whalen 103 34 51 178 24 388
Pablo N. Perez‐Guzman 53 21 174 57 16 385
Mary Glenshaw 153 60 225 22 25 408

All Works

Loading papers...

Rankless by CCL
2026